Given this, in this experiment, we explored the effect of paricalcitol on cisplatin-induced AKI from oxidative stress and inflammation, using HO-1 inhibitors to determine whether paricalcitol exerts nephroprotective effects through the Nrf2/HO-1 signaling pathway. The gene discussed is HMOX1; the disease is acute kidney injury.